Approvals/TGA/Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.25% (50mg/20mL) injection BP vial

Approved

STANDARD

Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.25% (50mg/20mL) injection BP vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 60c8b4a00fb28706
Product Name: Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.25% (50mg/20mL) injection BP vial
Artg Id: 11314
Artg Name: Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.25% (50mg/20mL) injection BP vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 1991-08-13
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/30fa992a253a3d444f7d8cd71b79bdfe.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/71ddb8c83b7eca25bc2742877469aafe.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

60c8b4a00fb28706

Type

Standard